# Amgen Inc. (NASDAQ: AMGN), Thousand Oaks, CA – FDA Inspections

Source: https://www.keypedia.com/companies/amgen-inc/bb4071de-7460-4602-9b6a-8266a6064a3a

> Inspection records and compliance data for Amgen Inc. in Thousand Oaks, CA. Access full analysis and detailed observations. Publicly traded as NASDAQ: AMGN.

---

## Details

- Name: Amgen Inc.
- Canada Business Number: 894837079
- Address Line 1: One Amgen Center Drive
- City: Thousand Oaks
- State: CA
- Zip Code: 91320-1799
- Country Name: United States
- Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States
- Country: United States

## Stock

- Stock ticker: AMGN
- Exchange: NASDAQ
- Share price: $467.06
- Market cap: $252.6B
- Price as of: November 13, 2026

## Related Documents

- Canada Inspection - Amgen Inc. - Inspection #88211 - 2025-03-04 — source: Canada, date: March 4, 2025
- Canada Inspection - Amgen Inc. - Inspection #84688 - 2024-01-29 — source: Canada, date: January 29, 2024
- Canada Inspection - Amgen Inc. - Inspection #84603 - 2023-11-21 — source: Canada, date: November 21, 2023
- Canada Inspection - Amgen Inc. - Inspection #74782 - 2019-12-09 — source: Canada, date: December 9, 2019
- Canada Inspection - Amgen Inc. - Inspection #69003 - 2017-04-11 — source: Canada, date: April 11, 2017
- Canada Inspection - Amgen Inc. - Inspection #54482 - 2016-05-24 — source: Canada, date: May 24, 2016
- Canada Inspection - Amgen Inc. - Inspection #14792 - 2014-08-12 — source: Canada, date: August 12, 2014
- Canada Inspection - Amgen Inc. - Inspection #13489 - 2013-03-20 — source: Canada, date: March 20, 2013
- Canada Inspection - Amgen Inc. - Inspection #3503 - 2013-03-18 — source: Canada, date: March 18, 2013
- Canada Inspection - Amgen Inc. - Inspection #12542 - 2012-12-12 — source: Canada, date: December 12, 2012

## Related Companies

- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/c9b5e737-30aa-45a5-b838-a5d051f27e16)
- [Kite Pharma, Inc.](https://www.keypedia.com/companies/kite-pharma-inc/fcc5c3d2-d53c-4978-84ae-8ad3d8c42355)
- [Janssen Pharmaceuticals Inc.](https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/33af6422-e7cf-4c0b-8e45-a59afccf2aa7)
- [KBI Biopharma Inc.](https://www.keypedia.com/companies/kbi-biopharma-inc/7415997e-ed64-4a04-be70-dd187cc94352)
- [Janssen Biotech Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/dde2af9e-62dc-4979-998f-faf10634d238)
- [Kashiv BioSciences, LLC](https://www.keypedia.com/companies/kashiv-biosciences-llc/a0550cff-2071-4a25-86c3-45017228318d)
- [Spark Therapeutics Inc](https://www.keypedia.com/companies/spark-therapeutics-inc/84137cbd-29ef-4bc3-8985-6cac00c08f36)
- [Swords Laboratories Unlimited Company t/a Bristol-Myers Squibb Cruiserath Biologics](https://www.keypedia.com/companies/swords-laboratories-unlimited-company-ta-bristol-myers-squibb-cruiserath-biologics/b12881e2-be6d-4b2b-9cc3-43baf991ecbf)
- [Rentschler Biopharma SE](https://www.keypedia.com/companies/rentschler-biopharma-se/0504364d-1aae-45d4-844e-acb77a055923)
- [Swedish Orphan Biovitrum AB](https://www.keypedia.com/companies/swedish-orphan-biovitrum-ab/8324dee2-a85c-445a-9ddd-e1d3abff31b8)